WO2020231368A1 - An intratympanic injection needle - Google Patents
An intratympanic injection needle Download PDFInfo
- Publication number
- WO2020231368A1 WO2020231368A1 PCT/TR2020/050320 TR2020050320W WO2020231368A1 WO 2020231368 A1 WO2020231368 A1 WO 2020231368A1 TR 2020050320 W TR2020050320 W TR 2020050320W WO 2020231368 A1 WO2020231368 A1 WO 2020231368A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- injection needle
- needle
- intratympanic
- injection
- middle ear
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
- A61F11/20—Ear surgery
- A61F11/202—Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3294—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles comprising means for injection of two or more media, e.g. by mixing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
This invention relates to an intratympanic injection needle (1) which is developed for middle ear injections and an apparatus containing said needle (1). The intratympanic injection needle (1) has been developed for middle ear injections. Intratympanic injection needle (1) comprises two needles such that one is shorter than the other, the longer one of these needles carries medicine to the middle ear while the other carries the air in the middle ear to the outer environment to reduce the pressure in the middle ear.
Description
AN INTRATYMPANIC INJECTION NEEDLE
Technical Field
The present invention relates to an intratympanic injection needle (1 ) which is developed for middle ear injections and an apparatus containing said needle. The intratympanic injection needle (1 ) has been developed for middle ear injections.
State of the Art
Intratympanic (IT) injection treatment is a treatment method for the medical treatment of cochlear diseases, wherein the medicine is directly injected to middle ear by an injector through the ear drum. Our aim here is to ensure that the medicine developed for the ear directly reaches the middle ear unlike the oral drugs. Major cochlear diseases for which intratympanic injection treatment is applied are; sensorineural hearing losses (sudden hearing loss and autoimmune hearing loss), vertigo, neoplastic, Meniere's disease and tinnitus (ringing in ears).
Studies of applying the medicines locally to inner ear first carried out in the 50s. First applications were the local anesthetic and antibiotic administrations to the middle ear with the Meniere's Disease. In 1956, Schuknecht administered IT streptomycin on Meniere's patients. However, severe hearing losses encountered due to use of streptomycin restricted the administration of this medicine. The opinion that the local gentamicin administration eliminated the symptoms without damaging the hearing much became popular in the 90s. In 1991 , Itoh and Sakata successfully experimented IT steroid therapy in Meniere patients. Today, IT applications are among the basic treatment options for various diseases and many studies have been provided to improve this application.
The biggest advantage of intratympanic injection therapy is that the medication used for treatment does not have systemic side effects, since it is only applied to the middle ear. Cortisone, which is used especially in the treatment of sudden hearing losses, can t
cause side effects that can result in fatal consequences such as stomach complaints, weight gaining and even gastric bleeding when administered orally as drug. However, since intratympanic injection therapy is effective locally, those side effects are out of question. In addition, intratympanic injection therapy is much more effective than other orally administered drugs used for both inner ear and middle ear, and recovery and processing periods are very short and positive results are obtained.
In the application of intratympanic injection, the eardrum where intratympanic injection will be applied is anaesthetized with a spray containing lidocaine. The ear which is anesthetized by spray should rest for a short time. The medicine is delivered to the middle ear by passing through the eardrum with a dental needle-tipped injector that is as thin as a hair. Since the hole in the eardrum is too small, the eardrum repairs itself immediately and no permanent hole is formed. Furthermore, the patient can easily go back to normal life shortly after the procedure is completed.
The middle ear cavity is a closed area. There is a connection between the eustachian tube and the nose, but this connection is closed when resting. With intratympanic injection, this space is completely filled with medicine (in liquid form) via injection. In the present art, dental needles are used; wherein, since the medicine is injected into the middle ear with a single needle, the pressure in the middle ear increases and therefore a mechanism is needed to discharge the air in the middle ear. This not only makes the injection difficult, but also makes the treatment more painful due to increased pressure. The patent application No EP 3 338 837 A1 in the state of the art relates to a syringe for intratympanic injection. Said intratympanic injection syringe includes a dental needle, wherein it includes a system by which the temperature change can be determined by the color change on the syringe and accordingly, injection is performed at the injection temperature. In the state of the art, patent document No JP6133464 B1 relates to an autoiogical injection needle containing a needle that allows to reduce damage to the tympanic cavity.
In the state of the art, no apparatus as solution has been developed for discharging the pressure in the middle ear during intratym panic injection; due to the above-mentioned problems and because of the inadequacy of the existing solutions, it has become
necessary to make an improvement in the technical field. The present invention relates to an intratympanic injection needle which eliminates those drawbacks, and to an intratympanic injection apparatus containing this needle.
Brief Description and Aims of the Invention
The present invention discloses an innovative intratympanic injection needle developed for intratympanic injection therapy, and an apparatus containing it.
An aim of the invention is to solve the pressure problem occurring in the middle ear during intratympanic injection therapy.
Another aim of the invention is to establish a system that discharges the air in middle ear simultaneously with injection info the middle ear.
A further aim of the invention is to make intrathympanic injection therapy painless and comfortable for the patient.
Another aim of the invention is to perform an effective intratympanic injection therapy without requiring an extra process or apparatus.
Definitions of the Figures Describing the invention
In order for the embodiment of the invention and the advantages thereof together with additional components to be better understood, the below explained figures should be taken into account while making evaluation. 1 : View of the intratympanic injection needle.
2 : Exploded view of the intratympanic injection needle.
3: General view of the syringe containing the intratympanic injection needle.
Definitions of Elements/Sections/Parts Constituting the Invention
In order to better describe the intratympanic injection needle and the intratympanic injection apparatus developed by this invention, the parts and sections disclosed in figures are numbered and the definition of each number are given below:
1. Intratympanic injection needle
2. Injection needle
3. Discharging needle
4. Compression lock
5. Injection apparatus
Detailed Description of the invention
The subject matter intratympanic injection needle (1 ) comprises an injection needle (2) and a discharging needle (3). The injection needle (2) delivers the medicine injected to the middle ear. The discharging needle (3) transports the air in the middle ear to the outer environment in order to balance the pressure formed as result of the injection in the middle ear. The sharp tips of the injection needle (2) and the discharging needle (3) are positioned at the tip of the intratympanic injection needle (1 ). The chamfered surfaces of the needles are positioned as facing the opposite directions so that the liquid injected with the injection needle (2) does not come out of the discharging needle
(3). The discharging needle (3), which ensures that the air in the middle ear is transported to the outer environment, is shorter compared to the injection needle (2). The reason of this is that the needle moves by bending in the ear while injection is performed. Since the injection needle (2) and discharging needle (3) combined by the compression lock
(4) will exhibit a more rigid behavior; A successful injection is achieved by performing the bending function only by the handle part of the injection needle (2).
Production method of the intraympathic injection needle (1 ) comprises the following process steps;
- Positioning the injection needle (2) and discharging needle (3) side by side such that their sharp tips are next to each other,
- Putting the compression lock (4) to the needles standing side by side,
Pressing the injection needle (2) and the discharging needle (3) to which the compression lock (4) is fitted such that they stand adjacent to each other by means of a press.
The intratympathic injection needle (1 ) can be produced in accordance with the injection apparatus (5) of any size by pressing the injection needle (2) and the discharging needle (3) of different diameters by means of compression locks having different sizes.
The subject matter intratympanic injection needle (1 ) is made of stainless steel.
The intratympathic injection needle (1 ) is used in all interventions which require injection into the middle ear.
The injection apparatus containing the subject matter intratympanic injection needle (1 ) can be a syringe or an injector.
Claims
1. An intratympanic injection needle (1 ), characterized in that; it comprises an injection needle (2) which delivers the medicine to be injected to middle ear, a discharging needle (3) which delivers the air in the middle ear to the outer environment in order to prevent pressure forming in the middle ear during injection, and a compression lock (4) for combining these needles.
2, An intratympanic injection needle (1 ) according to Claim 1 , characterized in that; the discharging needle (3) is shorter than the injection needle (2).
3, An intratympanic injection needle (1 ) according to Claim 1 , characterized in that; the sharp tips of the injection needle (2) and the discharging needle (3) are positioned side by side at the tip portion of the intratympanic injection needle (1 ).
4. An intratympanic injection needle (1 ) according to Claim 1 , characterized in that; the chamfered surfaces of the needles are positioned as facing the opposite directions so that the liquid injected via the injection needle (2) does not come out of the discharging needle (3).
5, An intratympanic injection needle (1 ) according to Claim 1 , characterized in that; it is made of stainless steel.
6. Production method of an intratympanic injection needle (1 ) according to any one of the preceding claims, characterized in that; it comprises the following process steps of
- Positioning the injection needle (2) and discharging needle (3) side by side such that their sharp tips are next to each other,
- Putting the compression lock (4) to the needles standing side by side, - Pressing the injection needle (2) and the discharging needle (3) to which the compression lock (4) is fitted such that they stand adjacent to each other by means of a press.
Use of an intratympanic injection needle (1 ) in all interventions which require injection into the middle ear according to any of Claims 1 to 5.
An injection apparatus (5) containing an intratympanic injection needle (1 ) according to any of Claims 1 to 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/07060A TR201907060A2 (en) | 2019-05-10 | 2019-05-10 | An intratympanic injection needle. |
| TR2019/07060 | 2019-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2020231368A1 true WO2020231368A1 (en) | 2020-11-19 |
Family
ID=73290307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/TR2020/050320 WO2020231368A1 (en) | 2019-05-10 | 2020-04-15 | An intratympanic injection needle |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201907060A2 (en) |
| WO (1) | WO2020231368A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2295471Y (en) * | 1997-01-24 | 1998-10-28 | 傅云朝 | Two pipe puncture needle for auripuncture |
| CN102397132A (en) * | 2010-09-09 | 2012-04-04 | 孙伟 | Eardrum puncture needle |
| CN108524100A (en) * | 2018-05-03 | 2018-09-14 | 张琦 | Auripuncture, Injection in Tympanic Cavity medical treatment device |
-
2019
- 2019-05-10 TR TR2019/07060A patent/TR201907060A2/en unknown
-
2020
- 2020-04-15 WO PCT/TR2020/050320 patent/WO2020231368A1/en active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2295471Y (en) * | 1997-01-24 | 1998-10-28 | 傅云朝 | Two pipe puncture needle for auripuncture |
| CN102397132A (en) * | 2010-09-09 | 2012-04-04 | 孙伟 | Eardrum puncture needle |
| CN108524100A (en) * | 2018-05-03 | 2018-09-14 | 张琦 | Auripuncture, Injection in Tympanic Cavity medical treatment device |
Also Published As
| Publication number | Publication date |
|---|---|
| TR201907060A2 (en) | 2020-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kiliç et al. | Intratympanic methylprednisolone for sudden sensorineural hearing loss | |
| MXPA03006217A (en) | Spaced drug delivery system. | |
| RU2515147C2 (en) | Injection needle | |
| US10130777B2 (en) | Injection needle | |
| WO2020231368A1 (en) | An intratympanic injection needle | |
| Fazel et al. | Evaluation and treatment of acute and subacute hearing loss: a review of pharmacotherapy | |
| US20140257183A1 (en) | Injection Site Indicator | |
| Galindo et al. | A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c≥ 9–15%: DUAL HIGH Trial | |
| Chu et al. | The efficacy of concurrent or sequential intravenous and intratympanic steroid for idiopathic sudden sensorineural hearing loss | |
| Ciodaro et al. | Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus? | |
| WO2013171907A1 (en) | Injection needle and kit preparation | |
| DiSogra et al. | Auditory and vestibular side effects of FDA-approved drugs for diabetes | |
| Craenmehr et al. | Follitropin-β administered by pen device has superior local tolerance compared with follitropin-α administered by conventional syringe | |
| RU2327437C1 (en) | Medicinal agent deliverer to posterior pole of eyeball and related method of medicinal agents delivery to posterior pole of eyeball | |
| RU2010108395A (en) | METHOD FOR TREATMENT OF CENTRAL SUBRETINAL HEMORRHAGE | |
| SE9901257D0 (en) | Treatment of pain after joint surgery | |
| Kadam et al. | Intratympanic Microwick Placement | |
| RU2094038C1 (en) | Method of treating neurosensor hearing disorder | |
| Rupasinghe | Comparison-effectiveness of oral steroid versus intratympanic Dexamethasone for sudden onset sensorineural hearing loss | |
| CN211068689U (en) | Administration tube, administration device, and neuropsychiatric disease treatment system | |
| CN101920063A (en) | Cavity mucous membrane administration apparatus, administration device and administration method | |
| GB2474646A (en) | Eye injection guide means | |
| Maksoud et al. | Intratympanic dexamethasone injection in Meniere’s disease | |
| Mimura et al. | Topical ocular drug delivery to inner ear disease and sinusitis | |
| Jassar et al. | Otic drops used to clear a blocked grommet: an in vitro prospective randomized controlled study with blinded assessment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20806355 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20806355 Country of ref document: EP Kind code of ref document: A1 |